Davis Polk advised the representatives of the initial purchasers in connection with a Rule 144A/Regulation S offering by NCL Corporation Ltd. of $850 million aggregate principal amount…
Davis Polk advised the joint book-running managers and the initial purchasers in a Rule 144A/Regulation S offering of $250 million principal amount of 3.000% senior secured notes due…
Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $728 million secondary offering of 17,343,037 of its Class A ordinary shares by certain selling…
Davis Polk advised the underwriters in connection with the offering of $1.25 billion aggregate principal amount of 1.125% bonds due October 7, 2030 issued by the Province of Ontario.
The…
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of €6.25 billion aggregate principal amount of notes by Medtronic Global…
Davis Polk advised the lead managers on an SEC-registered offering by TD Bank of $500 million aggregate principal amount of its floating-rate senior notes due 2023, under its medium-term…